The developer of products for biopharmaceutical companies and research and academic institutions files for bankruptcy.

Rep. Ted Davis has spent five years working on legislation that would make Chemours pay for PFAS-removing upgrades built by ...

Despite the technology in Avita’s RECELL system being in use since the Bali bombings in 2002, the product has had limited commercial success as it entered the market as an investigational device. This ...

Key trends and challenges are shaping the next era of advanced therapies, from FDA momentum to broader patient access.

Q1 2025 Earnings Call Transcript April 30, 2025 Guardant Health, Inc. beats earnings expectations. Reported EPS is $-0.49, ...

Helmy Eltoukhy; Chairman of the Board, Co-Chief Executive Officer; Guardant Health Inc Amirali Talasaz; Co-Chief Executive Officer, Director; Guardant Health Inc Hello, everybody, and welcome to the ...

Lumos Diagnostics is striving to become the leader in rapid point-of-care tests to distinguish between viral and bacterial ...

During the Biden administration, local food distributors were encouraged to apply for grants funding to help build ...

Before the Tribunal, Dept argued that expenses should have been capitalised by the assessee.

Q1 2025 Earnings Conference Call May 8, 2025 8:00 AM ET. Company Participants. Stephanie Fagan - Chief Corporate Affairs Officer Rob Bar ...

TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant ...